Hualan Biological Engineering (SZSE:002007) Change In Payables And Accrued Expense : ¥0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2004. Start your Free Trial

What is Hualan Biological Engineering Change In Payables And Accrued Expense?

Hualan Biological Engineering's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2025 was ¥0 Mil. It means Hualan Biological Engineering's Accounts Payable & Accrued Expense stayed the same from Dec. 2024 to Mar. 2025 .

Hualan Biological Engineering's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2024 was ¥0 Mil. It means Hualan Biological Engineering's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Dec. 2024 .

Hualan Biological Engineering Change In Payables And Accrued Expense Historical Data

The historical data trend for Hualan Biological Engineering's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hualan Biological Engineering Change In Payables And Accrued Expense Chart

Hualan Biological Engineering Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

Hualan Biological Engineering Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Hualan Biological Engineering Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Hualan Biological Engineering Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Hualan Biological Engineering's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Hualan Biological Engineering Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hualan Biological Engineering Inc (SZSE:002007) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1, Hualan Avenue, Henan Province, Xinxiang, CHN, 453003

Website

http://www.hualanbio.com

Hualan Biological Engineering Inc is a China-based biopharmaceutical company. It is engaged in the research, development, production, and commercialization of plasma products, viral vaccines, bacterial vaccines, and recombinant proteins and other biologics. The plasma products offered by the company include Human albumin, Human fibrinogen, Human tetanus immunoglobulin and others. The vaccines products include Recombinant hepatitis B vaccine, Inactivated influenza vaccine and other. It also offers gene products such as Monoclonal Antibody for tumor, autoimmune diseases, infectious diseases, transplant rejection, and Recombinant monoclonal antibodies.

Executives

Chen Zheng Yue	Executives
Fan Bei	Directors, executives
Pan Ruo Wen	Executives
Xie Jun Min	Directors, executives
An Wen Qi	Executives
An Kang	Directors, executives
Ma Xiao Wei	Executives
Zhang Bao Xian	Executives
An Wen Jue	Director
Liu Jun	Executives
Wang Qi Ping	Directors, executives
Lv Cheng Yu	Securities Affairs Representative
Zhang Jin Gang	Independent director
Wang Li Ting	Independent director
Ma Li	Supervisors

Hualan Biological Engineering Headlines

No Headlines